You are here:Home1/News Release2/EISAI TO PRESENT LATEST DATA ON LEMBOREXANT INCLUDING INTEGRATED ANALYSIS OF PHASE III CLINICAL STUDIES AT 33RD ANNUAL SLEEP MEETING
/wordpress/wp-content/uploads/2021/04/logo3.png00chen, chenyan/wordpress/wp-content/uploads/2021/04/logo3.pngchen, chenyan2019-05-29 00:00:002021-03-18 14:33:18EISAI TO PRESENT LATEST DATA ON LEMBOREXANT INCLUDING INTEGRATED ANALYSIS OF PHASE III CLINICAL STUDIES AT 33RD ANNUAL SLEEP MEETING